Congenital Melanocytic Nevi: Risk and Management
Congenital melanocytic nevi (CMN) are pigmented lesions present at birth or within the first few years of life. Their management varies based on size, location, and associated risks, particularly concerning melanoma development.
Topics: CMN, melanocytic, congenital
Overview / Definition Congenital melanocytic nevi (CMN) are benign neoplasms resulting from abnormal proliferation of melanocytes. These nevi are classified based on their size: small (20 cm). CMN can appear anywhere on the skin and may present differently based on their size and location. Epidemiology CMN occur in approximately 1-2% of newborns. The prevalence increases with the size of the nevus, with large nevi being rarer but more concerning due to the higher associated risk of melanoma. Small CMN: ~1-2% of the population Medium CMN: ~0.5% of the population Large CMN: ~1 in 20,000 births Pathophysiology / Mechanism CMN arise from genetic mutations in melanocyte precursor cells during embryonic development. The exact etiology remains unclear, but factors include: Mutations in the BRAF gene Changes in the NRAS gene Environmental influences, although these are less well defined Understanding the genetic basis assists in recognizing the potential for malignant transformation, particularly in larger nevi. Clinical Presentation CMN can vary widely in appearance: Color: Ranges from light brown to black Texture: Can be smooth or raised Hairiness: Often hairy, especially in larger lesions Location: Can be solitary or multiple, usually asymptomatic Large nevi, especially those over 20 cm, are at a significantly higher risk for developing melanoma, with a lifetime risk estimated at 5-10%. Diagnosis / Workup The diagnosis of CMN is primarily clinical. However, in cases where the diagnosis is uncertain or melanoma is suspected, further evaluation may be warranted: Clinical examination: Assess size, shape, color, and surface characteristics Dermatoscopy: Can provide detailed visualization of pigmentation patterns Biopsy: Considered if there is concern for atypical features or changes in the nevus Treatment / Management Management of CMN depends on the size and location of the nevus: Observation: For small and medium nevi without atypical features Excision: Recommended for lar